Complete pathologic response to neoadjuvant radiotherapy is predictive of oncological outcome in patients with soft tissue sarcoma

Dhruvil Shah, Dariusz Borys, Steve R. Martinez, Chin-Shang Li, Robert M. Tamurian, Richard J Bold, Arta M Monjazeb, Robert J Canter

Research output: Contribution to journalArticle

27 Scopus citations

Abstract

We sought to determine if complete pathological necrosis (pathCR) predicts favorable oncological outcome in soft tissue sarcoma (STS) patients receiving preoperative radiation monotherapy (RT). Patients and Methods: We evaluated 30 patients with primary STS treated with neoadjuvant RT followed by definitive resection, from 2000 to 2010 at our institution. We defined ≥95% tumor necrosis as pathCR. Results: There were 22 STS of the extremities (73%), 7 of the retroperitoneum (23%), and 1 (4%) of the trunk. The median pathological percentage of tumor necrosis was 35% (range 5-100%) with three tumors (10%) demonstrating pathCR. With a median follow-up of 40 months, the 5-year local recurrence-free survival (LRFS), distant recurrence-free survival (DRFS), and overall survival (OS) for the entire cohort were 100%, 61%±11%, and 69%±11%, respectively. Among patients with pathCR, 3-year DRFS was 100% compared to 63±11% in patients without pathCR (p=0.28). Conclusion: Following neoadjuvant RT for STS, pathCR is associated with a clinically but not statistically significant 37% improvement in 3-year DRFS.

Original languageEnglish (US)
Pages (from-to)3911-3916
Number of pages6
JournalAnticancer Research
Volume32
Issue number9
StatePublished - Sep 2012

Keywords

  • Preoperative radiotherapy
  • Soft tissue sarcoma
  • Survival
  • Tumor necrosis

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Fingerprint Dive into the research topics of 'Complete pathologic response to neoadjuvant radiotherapy is predictive of oncological outcome in patients with soft tissue sarcoma'. Together they form a unique fingerprint.

  • Cite this